Hyun Kim, MD
Pulmonary Disease · Minneapolis, MNNPI 1891885307
Payments from drug & device makers
Across 404 payments — averaging $3643.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$1M
- E.r. Squibb & Sons, L.L.C.$145K
- United Therapeutics Corporation$144K
- Takeda Pharmaceuticals U.S.A., Inc.$61K
- Boehringer Ingelheim International GmbH$53K
- Bristol Myers Squibb$26K
- plus $15K from 3 others
Across 15 payments — averaging $101.26 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 174 | $1,028,821 |
| E.r. Squibb & Sons, L.L.C. | 6 | $144,887 |
| United Therapeutics Corporation | 48 | $144,272 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $60,769 |
| Boehringer Ingelheim International GmbH | 94 | $52,659 |
| Bristol Myers Squibb | 3 | $25,733 |
| Boehringer Ingelheim Pharma GmbH & Co.kg | 59 | $8,801 |
| Roche Products Limited | 3 | $5,765 |
| Intuitive Surgical | 1 | $121 |
How this compares
$1,471,828 in reported general payments places this provider in the 95th percentile of 261 pulmonary disease providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Minneapolis
- Joanne BillingsMinneapolis$1.5M
- Patrick WrightMinneapolis$817K
- Jonathan HovdaMinneapolis$713K
- Kevin GrullonMinneapolis$618K
- Ralph SteeleMinneapolis$298K
- Marshall HertzMinneapolis$289K
- David IngbarMinneapolis$272K
- Mitchell KayeMinneapolis$248K
- Jordan DunitzMinneapolis$147K
- Ronald ReilkoffMinneapolis$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.